Aurobindo Pharma Limited has informed the Exchange regarding a press release dated October 23, 2023, titled "Eugia Pharma receives USFDA approval for Testosterone Cypionate Injection".
Press Release Oct 23 2023
Filed with NSE ·
6ix hasn’t read this filing yet.
Earlier from Aurobindo Pharma
- Press Release Aug 16 2023
- PR-Q1 FY 2023-24
- Earnings Presentation-Q1 FY 2023-24
- Q1 – UFR 2023-24
- Press Release Aug 12 2023
Later from Aurobindo Pharma
- Q2FY24
- Q2 – UFR 2023-24
- Press Release Nov 09 2023
- Aurobindo Pharma Ltd Press Release Nov 22 2023
- Press Release Nov 29 2023
Follow Aurobindo Pharma into a list and get an email when it puts out news.
Follow Aurobindo Pharma